“Efficacity of Gefitinib or Erlotinib for EGFR- mutant advanced non-small cell lung carcinoma”, Tuj-hlth, vol. 43, no. 6, pp. 25–32, Jan. 2022, Accessed: Nov. 01, 2026. Available: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11534